
NYSE:SNV
This summary was created by AI, based on 1 opinions in the last 12 months.
Synovus Financial, symbol SNV-N, is noted for being a high-quality, trusted regional bank. The company is currently merging with Pinnacle, a move that many experts believe promises positive growth opportunities in the short term. Analysts emphasize the bank's performance, particularly highlighting strong loan growth and a favorable steepening of the yield curve, which is beneficial due to falling short-term interest rates. Furthermore, there is considerable activity in the capital markets, contributing to the overall robust performance of the bank. With a dividend yield of 3.40%, Synovus Financial's stock is viewed as trading at a good multiple, making it an attractive investment option with an analysts’ price target of $55.87.
Synovus Financial is a American stock, trading under the symbol SNV (previously SNV-N on Stockchase) on the New York Stock Exchange (SNV). It is usually referred to as NYSE:SNV or SNV
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SNV (previously SNV-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Synovus Financial.
Synovus Financial was recommended as a Top Pick by Gordon Reid on 2025-10-21. Read the latest stock experts ratings for Synovus Financial.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Synovus Financial.
Synovus Financial is covered by Stockchase experts and is worth watching.
On 2025-12-31, Synovus Financial (SNV) stock closed at a price of $51.50.
High-quality, trusted regional bank. Merging with Pinnacle, showing good promise for even short-term growth. Trades at a good multiple. Loan growth is good. Yield curve is steepening, with short-term interest rates falling, and that's very good for banks. A fair bit of capital markets business is also happening. Yield is 3.40%.
(Analysts’ price target is $55.87)